NEW ORLEANS , LA, UNITED STATES, March 19, 2026 /EINPresswire.com/ -- HeartLung.AI today announced that it will ...

The FDA has approved the Trilogy Transcatheter Heart Valve System for treating patients with symptomatic severe aortic ...

I had breast cancer in my left breast 14 years ago. I was treated with chemotherapy and radiation after a lumpectomy and the removal of 14 lymph ...

Pune: A complicated heart procedure conducted by doctors at a private hospital in Pune saved the life of a 60-year-old man ...

I’m a 79-year-old female. Recently, I was diagnosed with moderate calcification of leaflets on my mitral valve. I have no ...

The FDA approved the Trilogy Transcatheter Heart Valve System for the treatment of symptomatic severe aortic regurgitation, device maker JenaValve Technology announced. This approval makes Trilogy the ...

With its FDA approval, JenaValve intends to commence launch activity for the Trilogy System immediately with participating ...

JenaValve's Trilogy System, FDA-approved for severe AR, offers secure anchoring without calcium. It is a breakthrough for ...

Recently, a patient came to the hospital where I work with a persistent cough. Their doctor had ordered a CT scan—a type of imaging that creates detailed cross-sectional pictures of the body's ...

JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket ...

Approval marks a historic milestone for Americans living with ssAR who are at high risk for surgery and previously had no dedicated transcatheter treatment option ...

Sports cardiology has emerged as a distinct subspecialty at the intersection of preventive cardiology and athlete care. While ...